HDE

BH220740: Selective Cytopheretic Device (SCD-PED)

FDA Humanitarian Device Exemption · SeaStar Medical

Key facts

HDE number BH220740
Trade name Selective Cytopheretic Device (SCD-PED)
Generic name Pediatric extracorporeal synthetic semipermeable membrane cartridge for acute kidney injury
Applicant SeaStar Medical
Owner/operator SeaStar Medical, Inc.
Product code QZV
Approval date Feb 21, 2024
Establishment registration 3015045325
FEI number 3015045325

At a glance

  • None Supplements
  • Feb 21, 2024 Latest supplement decision
  • No Summary of safety and probable benefit on file
  • None UDI device identifiers (GUDID)
  • None MAUDE adverse event reports
  • None Recall events

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About HDE approvals

A Humanitarian Device Exemption (HDE) authorizes devices intended to benefit patients with rare diseases or conditions affecting small populations in the United States.

Source: U.S. Food and Drug Administration (FDA), Humanitarian Device Exemption (HDE) database · Source date:

Browse all HDE approvals